Prevalent bacterial infections in intensive care units of Shiraz University of Medical Sciences Teaching Hospitals, Shiraz, Iran

Japanese Journal of Infectious Diseases

Volumn 62, Issue 4, 2009, Pages 249-253

  Hassanzadeh, Parvin ^a   Motamedifar, Mohammad ^b   Hadi, Nahal ^b  

^a SHIRAZ UNIVERSITY   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; CEFAZOLIN; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; DISK DIFFUSION; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; INTENSIVE CARE UNIT; IRAN; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PSEUDOMONAS; RESPIRATORY SYSTEM; STAPHYLOCOCCUS; TEACHING HOSPITAL; URINARY TRACT INFECTION; WOUND; BACTERIUM; CLASSIFICATION; CROSS INFECTION; CROSS-SECTIONAL STUDY; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIA; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITALS, TEACHING; HUMANS; INFANT; INTENSIVE CARE UNITS; IRAN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREVALENCE; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 69449107203     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Vincent, J.L., Bihari, D.J., Suter, P.M., et al. (1995): The prevalence of nosocomial infection in intensive care units in Europe-results of the European Prevalence of Infection in Intensive Care (EPIC) Study. JAMA, 274, 639-644.
2. Tennant, I., Harding, H., Nelson, M., et al. (2005): Microbial isolates from patients in an intensive care unit, and associated risk factors. West Indian Med. J., 54, 225-231.
3. Bayram, A. and Balci, I. (2006): Patterns of antimicrobial resistance in a surgical intensive care unit of a university hospital in Turkey. BMC Infect. Dis., 6, 155.
4. Girou, E., Stephan, F., Novara, A., et al. (1998): Risk factors and outcome of nosocomial infections: result of a matched case - control study of ICU patients. Am. J. Respir. Crit. Care Med., 4, 1151-1158.
5. Sallam, S.A., Arafs, M.A., Razek, A.A., et al. (2005): Device-related nosocomial infection in intensive care units of Alexandria University Students Hospital. East Mediterr. Health J., 11, 52-61.
6. Jarvis, W.R., Edwards, J.R., Culver, D.H., et al. (1991): Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomical Infections Surveillance System. Am. J. Med., 91, 185S-191S.
7. Weber, D.J., Raasch, R. and Rutala, W.A. (1999): Nosocomial infection in the ICU. Chest, 115, 34S-41S.
8. Esen, S. and Leblebicioglu, H. (2009): Prevalence of nosocomial infections at intensive care units in Turkey multi center 7-day point prevalence study. Scand. J. Infect. Dis., 36, 144-148.
9. Richards, M., Thursky, K. and Buising, K. (2003): Epidemiology, prevalence, and sites of infections in intensive care units. Semin. Respir. Crit. Care Med., 24, 3-22.
10. Ylipalosaari, P., Ala-Kokko, T.I., Laurila, J., et al. (2006): Intensive care aquired infection is an independent risk factor for hospital mortality a prospective cohort study. Crit. Care, 10, R66.
11. Trilla, A. (1994): Epidemiology of nosocomial infections in adult intensive care units. Intensive Care Med., 20 (Suppl. 3), S1-S4.
12. Haley, R.W., Culver, D.H., White, J.W., et al. (1985): The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am. J. Epidemiol., 121, 182-205.
13. Garner, J.S., Jarvis, W.R., Emori, T.G., et al. (1988): CDC definitions for nosocomial infections. Am. J. Infect. Control, 16, 128-140.
14. Eggimann, P. and Pitted, D. (2001): Infection control in the ICU. Chest, 120, 2059-2093.
15. National Committee for Clinical Laboratory Standards (2000): Performance Standards for Antimicrobial Disk Susceptibility Tests. 5th ed. Approved Standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
16. Clinical and Laboratory Standards Institute (2005): Document M100-S15. Performance Standards for Antimicrobial Susceptibility Testing. 15th informational supplement. Clinical and Laboratory Standards Institute, Wayne, Pa.
17. Ylipalosaari, P., Ala-Kokko, T.I., Laurila, J., et al. (2006): Epidemiology of intensive care unit (ICU)-acquired infections in a 14-month prospective cohort study in a single mixed Scandinavian university hospital ICU. Acta Anaesthesiol. Scand., 50, 1192-1197.
18. Shehabi, A.A. and Baadran, I. (1995): Microbial infection and antibiotic resistance patterns among Jourdanian intensive care patients. East Mediterr. Health J., 2, 515-520.
19. Verhoef, J., Verhage, E.A. and Vissoz, M.R. (1993): A decade of experience with selective decontamination of the digestive tract as prophylaxis for infections in patients in the intensive care unit: what have we learned? Clin. Infect. Dis., 17, 1047-1054.
20. Goldmann, D.A. and Pier, G.B. (1993): Pathogenesis of infections related to intravascular catheterization. Clin. Microbiol. Rev., 6, 176-192.
21. Dasehner, F.D., Frey, P., Wolff, G., et al. (1982): Nosocomial infections in intensive care wards: a multicenter prospective study. Intensive Care Med., 8, 5-9.
22. Richards, M.J., Edwards, J.R., Culver, D.H., et al. (1999): Nosocomical infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit. Care Med., 27, 887-892.
23. Khuri-Bulos, N.A., Shennak, M., Agabi, S., et al. (1999): Nosocomical infections in medical intensive care units at a university hospital in a developing country: comparison between national nosocomical infections surveillance intensive care unit rates. Am. J. Infect. Control, 27, 547-552.
24. Abdel-Fattah, M.M. (2005): Surveillance of nosocomial infections at a Saudi Arabian military hospital for a one-year period. Ger. Med. Sci., 3, Doc06.
25. Rizvi, M.F., Hasan, Y., Memon, A.R., et al. (2007): Pattern of nosocomial infection in two intensive care units of a tertiary care hospital in Karachi. J. Coll. Physicians Surg. Pak., 17, 136-139.
26. Fomsgaard, A., Høiby, N., Friis, H.M., et al. (1995): Prevalence and antibiotic sensitivity of Danish versus other European bacterial isolates from intensive care and hematology/oncology units. Eur. J. Clin. Microbiol. Infect. Dis., 14, 275-281.
27. Nicoletti, G., Schito, G., Fadda, G., et al. (2006): Bacterial isolates from severe infections and their antibiotic susceptibility patterns in Italy: a nationwide study in the hospital setting. J. Chemother., 18, 589-602.
28. Toufen Junior, C., Hovnanian, A.L., Franca, S.A., et al. (2003): Prevalence rates of infection in intensive care units of a tertiary teaching hospital. Rev. Hosp. Clin. Fac. Med. Sao Paulo, 58, 254-259.
29. Bergogne-Bérézin, E. (1999): Current guidelines for the treatment and prevention of nosocomial infections. Drugs, 58, 54-67.
30. Green, D.L. (2005): Selection of an empiric antibiotic regimen for hospital-acquired pneumonia using a unit and cultare-type specific antibiogram. J. Intensive Care Med., 20, 296-301.
31. Dai, C.M., Zhou, J.D., Wu, Y., et al. (2006): Distribution of pathogen and resistance of nosocomical infection in the intensive care unit. Zhong Nan Da Xue Bao Yi Xue Ban, 31, 277-280.
32. Mamishi, S., Pourakbari, B., Ashtiani, M.H., et al. (2005): Frequency of isolation and antimicrobial susceptibility of bacteria isolated from bloodstream infections at children's medical center, Tehran, Iran, 1996-2000. Int. J. Antimicrob. Agents, 26, 373-379.
33. Winokur, P.L., Canton, R., Casellas, J.M., et al. (2001): Variations in the prevalence of strains expressing an extended spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin. Infect. Dis., 15, 32 (Suppl. 2), S94-S103.
34. Gates, A.C., Jones, R.N., Forward, K.R., et al. (2001): Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin. Infect. Dis., 32 (Suppl. 2), S104-S113.
35. Oplustil, C.P., Nunes, R. and Mendes, C. (2001): Multicenter evaluation of resistance patterns of Klebsiella pneumoniae, Escherichia coli, Salmonella spp., and Shigella spp. isolated from clinical specimens in Brazil: RESISTNET Surveillance Program. Braz. J. Infect. Dis., 5, 8-12.
36. Issaragrisil, S., Kaufman, D.W., Anderson, T., et al. (1997): Low drug attributability of aplastic anemia in Thailand. The Aplastic Anemia Study Group. Blood, 89, 4034-4039.
37. Jones, R.N., Pfaller, M.A., Doern, G.V., et al. (1998): Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group. Diagn. Microbiol. Infect. Dis., 30, 215-228.
38. Karlowsky, J.A., Jones, M.E., Draghi, D.C., et al. (2004): Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002. Ann. Clin. Microbiol. Antimicrob., 3, 7-14.
39. Pfaller, M.A., Jones, R.N., Doern, G.V., et al. (1998): Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada) 1997. Antimicrob. Agents Chemother., 42, 1762-1770.
40. Rastegar Lari, A., Bahrami Honar, H. and Alaghehbandan, R. (1998): Pseudomonas infections in Tohid Burn Center, Iran. Burns, 24, 637-641.
41. Assadian, O., Askarian, M., Stadler, M., et al. (2007): Prevalence of vancomycin-resistant enterococci colonization and its risk factors in chronic hemodialysis patients in Shiraz, Iran. BMC Infect. Dis., 7, 52.